A

Ann & Robert H. Lurie Children's Hospital of Chicago | Gastroenterology, Hepatology and Nutrition Department

Research site

(Unclaimed)

Location

225 E Chicago Avenue, Chicago, Illinois, United States of America

Site insights

Top conditions

Top treatments

Cysteamine Bitartrate

Bevacizumab

Cytarabine

Etoposide phosphate

Vedolizumab

Voriconazole

Mycophenolate Mofetil

Methotrexate

Thalidomide

2-chlorodeoxyadenosine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 43 total trials

A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy (NURTURE)

The primary objective of the study is to examine the efficacy of multiple doses of Nusinersen administered intrathecally in preventing or delaying th...

Active, not recruiting

Spinal Muscular Atrophy

Drug: Nusinersen

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

This study is being conducted to test the safety and efficacy of ramucirumab in combination with other chemotherapy in the treatment of relapsed, rec...

Active, not recruiting

Desmoplastic Small Round Cell Tumor

Drug: Ramucirumab

Drug: Cyclophosphamide

Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections (TANGOKIDS)

A single dose infusion of Vabomere (meropenem-vaborbactam) is being tested for dose-finding, pharmacokinetics, safety, and tolerability in pediatric...

Enrolling

Bacterial Infections

Drug: Vabomere

Extension Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Who Previously Participated in a Study With Nusinersen (ONWARD)

The primary objective of this study is to evaluate the long-term safety and tolerability of nusinersen administered intrathecally at higher doses to...

Invitation-only

Muscular Atrophy, Spinal

Drug: Nusinersen

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

The study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBS...

Enrolling

Lupus Nephritis

Drug: Mycophenolate Mofetil